Targeting tumor-specific T cells with LAG3-directed interleukin-2 prevents T-cell exhaustion and reinvigorates antitumor immunity
Xiaohong Yu, Huiping Liao, Jiaoyun Lv, Yu Sun, Ruiqi Zhang, Yiwei Chen, Yifan Lin, Lulu Liu, Shijie Li, Hui Tang, Panpan Jia, Bin Shao, Zaopeng Yang, Yang-Xin Fu, Zhenhua Ren · 2026
Read Targeting tumor-specific T cells with LAG3-directed interleukin-2 prevents T-cell exhaustion and reinvigorates antitumor immunity by Xiaohong Yu, Huiping Liao, Jiaoyun Lv, Yu Sun, Ruiqi Zhang, Yiwei Chen, Yifan Lin, Lulu Liu, Shijie Li, Hui Tang, Panpan Jia, Bin Shao, Zaopeng Yang, Yang-Xin Fu, Zhenhua Ren (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13230990.txt.
Description
Xiaohong Yu and colleagues engineer in 2026 a targeted immune booster that revives tired T cells inside colon tumors in mice. Most tumor-specific T cells there carry the brake marker LAG3 and respond poorly to interleukin-2, a growth signal. The team fused a weak form of that signal to a LAG3-seeking part so only those cells receive it.
Treated cells multiplied, shifted toward an active fighter state, and avoided final exhaustion. Tumors shrank and mice lived longer in the model. The treatment also rebuilt a key signaling chain inside the cells by raising a receptor subunit. Fighter and memory cells grew in nearby lymph nodes too, giving protection against distant tumors and return of disease.
Catalog record
| CREATOR | Xiaohong Yu, Huiping Liao, Jiaoyun Lv, Yu Sun, Ruiqi Zhang, Yiwei Chen, Yifan Lin, Lulu Liu, Shijie Li, Hui Tang, Panpan Jia, Bin Shao, Zaopeng Yang, Yang-Xin Fu, Zhenhua Ren |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 59 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |